INTERNATIONAL PATENT: UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ, JOHANNES GUTENBERG-UNIVERSITAT MAINZ FILES APPLICATION FOR "SELECTIVE ANTIBODY-DRUG CONJUGATES FOR TARGETED CANCER THERAPY"

GENEVA, Feb. 2 -- UNIVERSITATSMEDIZIN DER JOHANNES GUTENBERG-UNIVERSITAT MAINZ (LangenbeckstraBe 155131 Mainz), JOHANNES GUTENBERG-UNIVERSITAT MAINZ (SaarstraBe2155122 Mainz) filed a patent application (PCT/EP2025/070501) for "SELECTIVE ANTIBODY-DRUG CONJUGATES FOR TARGETED CANCER THERAPY" on Jul 17, 2025. With publication no. WO/2026/021993, the details related to the patent application was published on Jan 29, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): BOPP, Tobias (Biebricher Allee 1465187 Wiesbaden), BESENIUS, Pol (BebelstraBe 67A55128 Mainz), ATTARIYA-HEFNAWY, Riem (Walter-Hallstei...